197 related articles for article (PubMed ID: 32766783)
1. Identification and characterization of hippuristanol-resistant mutants reveals eIF4A1 dependencies within mRNA 5' leader regions.
Steinberger J; Shen L; J Kiniry S; Naineni SK; Cencic R; Amiri M; Aboushawareb SAE; Chu J; Maïga RI; Yachnin BJ; Robert F; Sonenberg N; Baranov PV; Pelletier J
Nucleic Acids Res; 2020 Sep; 48(17):9521-9537. PubMed ID: 32766783
[TBL] [Abstract][Full Text] [Related]
2. mRNA structural elements immediately upstream of the start codon dictate dependence upon eIF4A helicase activity.
Waldron JA; Tack DC; Ritchey LE; Gillen SL; Wilczynska A; Turro E; Bevilacqua PC; Assmann SM; Bushell M; Le Quesne J
Genome Biol; 2019 Dec; 20(1):300. PubMed ID: 31888698
[TBL] [Abstract][Full Text] [Related]
3. The RNA Helicase eIF4A Is Required for Sapovirus Translation.
Hosmillo M; Sweeney TR; Chaudhry Y; Leen E; Curry S; Goodfellow I; Cho KO
J Virol; 2016 May; 90(10):5200-5204. PubMed ID: 26937032
[TBL] [Abstract][Full Text] [Related]
4. A novel Bcr-Abl-mTOR-eIF4A axis regulates IRES-mediated translation of LEF-1.
Tsai BP; Jimenez J; Lim S; Fitzgerald KD; Zhang M; Chuah CT; Axelrod H; Wilson L; Ong ST; Semler BL; Waterman ML
Open Biol; 2014 Nov; 4(11):140180. PubMed ID: 25392452
[TBL] [Abstract][Full Text] [Related]
5. eIF4B stimulates translation of long mRNAs with structured 5' UTRs and low closed-loop potential but weak dependence on eIF4G.
Sen ND; Zhou F; Harris MS; Ingolia NT; Hinnebusch AG
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10464-72. PubMed ID: 27601676
[TBL] [Abstract][Full Text] [Related]
6. eIF4A alleviates the translational repression mediated by classical secondary structures more than by G-quadruplexes.
Waldron JA; Raza F; Le Quesne J
Nucleic Acids Res; 2018 Apr; 46(6):3075-3087. PubMed ID: 29471358
[TBL] [Abstract][Full Text] [Related]
7. Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence.
Raza F; Waldron JA; Quesne JL
Biochem Soc Trans; 2015 Dec; 43(6):1227-33. PubMed ID: 26614665
[TBL] [Abstract][Full Text] [Related]
8. Selective pharmacological targeting of a DEAD box RNA helicase.
Lindqvist L; Oberer M; Reibarkh M; Cencic R; Bordeleau ME; Vogt E; Marintchev A; Tanaka J; Fagotto F; Altmann M; Wagner G; Pelletier J
PLoS One; 2008 Feb; 3(2):e1583. PubMed ID: 18270573
[TBL] [Abstract][Full Text] [Related]
9. Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules.
Singh K; Lin J; Lecomte N; Mohan P; Gokce A; Sanghvi VR; Jiang M; Grbovic-Huezo O; Burčul A; Stark SG; Romesser PB; Chang Q; Melchor JP; Beyer RK; Duggan M; Fukase Y; Yang G; Ouerfelli O; Viale A; de Stanchina E; Stamford AW; Meinke PT; Rätsch G; Leach SD; Ouyang Z; Wendel HG
Cancer Res; 2021 Apr; 81(8):2002-2014. PubMed ID: 33632898
[TBL] [Abstract][Full Text] [Related]
10. The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape.
Modelska A; Turro E; Russell R; Beaton J; Sbarrato T; Spriggs K; Miller J; Gräf S; Provenzano E; Blows F; Pharoah P; Caldas C; Le Quesne J
Cell Death Dis; 2015 Jan; 6(1):e1603. PubMed ID: 25611378
[TBL] [Abstract][Full Text] [Related]
11. Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products.
Shen L; Pelletier J
Nat Prod Rep; 2020 May; 37(5):609-616. PubMed ID: 31782447
[TBL] [Abstract][Full Text] [Related]
12. Coupling of Translation Initiation and Termination Does Not Depend on the Mode of Initiation.
Sogorin EA; Selikhanov GK; Agalarov SC
Biochemistry (Mosc); 2017 Jul; 82(7):816-820. PubMed ID: 28918745
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Mediated Drug-Target Validation Reveals Selective Pharmacological Inhibition of the RNA Helicase, eIF4A.
Chu J; Galicia-Vázquez G; Cencic R; Mills JR; Katigbak A; Porco JA; Pelletier J
Cell Rep; 2016 Jun; 15(11):2340-7. PubMed ID: 27239032
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A.
Bordeleau ME; Mori A; Oberer M; Lindqvist L; Chard LS; Higa T; Belsham GJ; Wagner G; Tanaka J; Pelletier J
Nat Chem Biol; 2006 Apr; 2(4):213-20. PubMed ID: 16532013
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation.
Rubio CA; Weisburd B; Holderfield M; Arias C; Fang E; DeRisi JL; Fanidi A
Genome Biol; 2014; 15(10):476. PubMed ID: 25273840
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI.
Zakowicz H; Yang HS; Stark C; Wlodawer A; Laronde-Leblanc N; Colburn NH
RNA; 2005 Mar; 11(3):261-74. PubMed ID: 15661843
[TBL] [Abstract][Full Text] [Related]
17. Eukaryotic initiation factor 4A (eIF4A) during viral infections.
Montero H; Pérez-Gil G; Sampieri CL
Virus Genes; 2019 Jun; 55(3):267-273. PubMed ID: 30796742
[TBL] [Abstract][Full Text] [Related]
18. FGFR1-Activated Translation of WNT Pathway Components with Structured 5' UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation Initiation.
Nguyen TM; Kabotyanski EB; Dou Y; Reineke LC; Zhang P; Zhang XH; Malovannaya A; Jung SY; Mo Q; Roarty KP; Chen Y; Zhang B; Neilson JR; Lloyd RE; Perou CM; Ellis MJ; Rosen JM
Cancer Res; 2018 Aug; 78(15):4229-4240. PubMed ID: 29844125
[TBL] [Abstract][Full Text] [Related]
19. The Translation Inhibitor Rocaglamide Targets a Bimolecular Cavity between eIF4A and Polypurine RNA.
Iwasaki S; Iwasaki W; Takahashi M; Sakamoto A; Watanabe C; Shichino Y; Floor SN; Fujiwara K; Mito M; Dodo K; Sodeoka M; Imataka H; Honma T; Fukuzawa K; Ito T; Ingolia NT
Mol Cell; 2019 Feb; 73(4):738-748.e9. PubMed ID: 30595437
[TBL] [Abstract][Full Text] [Related]
20. eIF4B stimulates eIF4A ATPase and unwinding activities by direct interaction through its 7-repeats region.
Andreou AZ; Harms U; Klostermeier D
RNA Biol; 2017 Jan; 14(1):113-123. PubMed ID: 27858515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
